Methods of Determining Plasma and Tissue Binding of Drugs
暂无分享,去创建一个
[1] P. K. Smith,et al. The interaction of barbiturates with serum albumin and its possible relation to their disposition and pharmacological actions. , 1954, The Journal of pharmacology and experimental therapeutics.
[2] B. Whiting,et al. Factors affecting drug binding in plasma of elderly patients. , 1976, British journal of clinical pharmacology.
[3] R. Braithwaite,et al. Techniques for plasma protein binding of demethylchlorimipramine , 1979, Clinical pharmacology and therapeutics.
[4] H A Feldman,et al. Mathematical theory of complex ligand-binding systems of equilibrium: some methods for parameter fitting. , 1972, Analytical biochemistry.
[5] J. Kampmann,et al. Quantitative and qualitative binding characteristics of disopyramide in serum from patients with decreased renal and hepatic function. , 1987, British journal of clinical pharmacology.
[6] D. Sandnes,et al. Binding of theophylline in human serum determined by ultrafiltration and equilibrium dialysis. , 1983, British journal of clinical pharmacology.
[7] R. P. Maickel,et al. Subcellular distribution of weak acids and bases in adrenal medulla. , 1982, General pharmacology.
[8] J. Perrin,et al. Conformational changes in human serum albumin around the neutral pH from circular dichroic measurements. , 1979, Biochimica et biophysica acta.
[9] C. Cerletti,et al. SUBCELLULAR DISTRIBUTION OF ETORPHINE IN RAT BRAIN AND EVIDENCE FOR in vivo STEREOSPECIFIC BINDING , 1978, British journal of pharmacology.
[10] M. Anttila,et al. Effect of food, food constituents and fluid volume on the bioavailability of sotalol. , 2009, Acta pharmacologica et toxicologica.
[11] T. Trnovec,et al. Different binding of propranolol enantiomers to human alpha 1-acid glycoprotein. , 1989, Biochemical pharmacology.
[12] P. McNamara,et al. Tissue binding of drugs. , 1977, Journal of pharmaceutical sciences.
[13] R. Andersson,et al. Biochemical and morphological characterization of subcellular fractions isolated from rabbit colon muscle. , 2009, Acta pharmacologica et toxicologica.
[14] C. Post,et al. Studies on the pharmacokinetic function of the lung with special reference to lidocaine. , 2009, Acta pharmacologica et toxicologica.
[15] W. Dreyer,et al. Measurement of protein-binding phenomena by gel filtration. , 1962, Biochimica et biophysica acta.
[16] B. Fichtl,et al. Binding of drugs to tissues. , 1983, Drug metabolism reviews.
[17] B. Rosen,et al. A multichamber equilibrium dialysis apparatus. , 1972, Analytical biochemistry.
[18] C. Kasper. [26] Isolation and properties of the nuclear envelope , 1974 .
[19] C. Kunin. Binding of antibiotics to tissue homogenates. , 1970, The Journal of infectious diseases.
[20] R. Vestal,et al. Uptake of propranolol by the lung and its displacement by other drugs: involvement of the alveolar macrophage. , 1980, Pharmacology.
[21] A. Pruitt,et al. Furosemide binding to human albumin and plasma of nephrotic children , 1975, Clinical pharmacology and therapeutics.
[22] C. Chignell. Optical Studies of Drug-Protein Complexes , 1969 .
[23] W. Jusko,et al. Determination and prediction of tissue binding of prednisolone in the rabbit. , 1984, Journal of pharmaceutical sciences.
[24] J F Zaroslinski,et al. Effect of temperature on the binding of salicylate by human serum albumin. , 1974, Biochemical pharmacology.
[25] I. Sjöholm,et al. Improved stability of proteins immobilized in microparticles prepared by a modified emulsion polymerization technique. , 1978, Journal of pharmaceutical sciences.
[26] M. Carrai,et al. The effect of ageing on plasma albumin and plasma protein binding of diazepam, salicylic acid and digitoxin in healthy subjects and patients with renal impairment. , 1992, British journal of clinical pharmacology.
[27] I. Gonda,et al. LUNG ACCUMULATION OF SOME β‐ADRENOCEPTOR ANTAGONISTS , 1978 .
[28] W. Lindup. Methods for the measurement of drug binding to plasma proteins , 1980 .
[29] A. Rane,et al. Clonazepam serum protein binding during development , 1984, Clinical pharmacology and therapeutics.
[30] B. Sébille,et al. The binding of drugs to blood plasma macromolecules: recent advances and therapeutic significance , 1984 .
[31] T. Ludden,et al. Binding of organic compounds to rat liver and lung. , 1976, Drug Metabolism And Disposition.
[32] V. Ringberger,et al. Protein binding of salicylate in uremic and normal plasma , 1976, Clinical pharmacology and therapeutics.
[33] I. Sjöholm,et al. Direct and indirect determination of binding constants of drug-protein complexes with microparticles. , 1978, Journal of pharmaceutical sciences.
[34] M. Carrai,et al. Effects of development, aging, and renal and hepatic insufficiency as well as hemodialysis on the plasma concentrations of albumin and alpha 1-acid glycoprotein: implications for binding of drugs. , 1986, Therapeutic drug monitoring.
[35] I. M. Klotz,et al. Properties of graphical representations of multiple classes of binding sites. , 1971, Biochemistry.
[36] M. Bickel,et al. Characterization of drug distribution and binding competition by two-chamber and multi-chamber distribution dialysis. , 1987, Journal of pharmaceutical sciences.
[37] G. Levy,et al. Distribution of salicylate between neonatal and maternal serum at diffusion equilibrium , 1975, Clinical pharmacology and therapeutics.
[38] F. Belpaire,et al. Binding of drugs in serum, blood cells and tissues of rabbits with experimental acute renal failure. , 1981, Pharmacology.
[39] J. Lima,et al. Stereoselective binding of disopyramide to human plasma protein. , 1984, Life sciences.
[40] L. Schanker,et al. PHYSIOLOGICAL DISPOSITION OF GUANETHIDINE IN THE RAT AND ITS UPTAKE BY HEART SLICES. , 1965, International journal of neuropharmacology.
[41] H. Mehendale,et al. Absence of metabolism of morphine during accumulation by isolated perfused rabbit lung. , 1979, Drug metabolism and disposition: the biological fate of chemicals.
[42] A. Guarino,et al. Subcellular localization of cis-dichlorodiammineplatinum(II) in rat kidney and liver. , 1980, Toxicology and applied pharmacology.
[43] M. Carrai,et al. Interindividual variability in the concentrations of albumin and alpha-1-acid glycoprotein in patients with renal or liver disease, newborns and healthy subjects: implications for binding of drugs. , 1992, International journal of clinical pharmacology, therapy, and toxicology.
[44] A. Rane,et al. Plasma protein binding of diphenylhydantoin in man; Interaction with other drugs and the effect of temperature and plasma dilution , 1970, Clinical pharmacology and therapeutics.
[45] L. Notarianni. Plasma Protein Binding of Drugs in Pregnancy and in Neonates , 1990, Clinical pharmacokinetics.
[46] I. Sjöholm,et al. Binding of drugs to human serum albumin:XI. The specificity of three binding sites as studied with albumin immobilized in microparticles. , 1979, Molecular pharmacology.
[47] S Oie,et al. Effect of altered plasma protein binding on apparent volume of distribution. , 1979, Journal of pharmaceutical sciences.
[48] T. Orton,et al. Xenobiotic accumulation and metabolism by isolated perfused rabbit lungs. , 1973, The Journal of pharmacology and experimental therapeutics.
[49] D. Ofori-Adjei,et al. Protein binding of chloroquine enantiomers and desethylchloroquine. , 1986, British journal of clinical pharmacology.
[50] Bernard,et al. Advances in Drug Research , 1964 .
[51] Y. Sugiyama,et al. Comparison between in‐vivo and in‐vitro tissue‐to‐plasma unbound concentration ratios (Kp,f) of quinidine in rats , 1984, The Journal of pharmacy and pharmacology.
[52] G. Rolinson,et al. The binding of antibiotics to serum proteins. , 1965, British journal of pharmacology and chemotherapy.
[53] U. Wollert,et al. Interaction of benzodiazepine derivatives with bovine serum albumin-I Gel filtration studies. , 1976, Biochemical pharmacology.
[54] G. Wilkinson,et al. The disposition of propranolol. IV. A dominant role for tissue uptake in the dose-dependent extraction of propranolol by the perfused rat liver. , 1973, The Journal of pharmacology and experimental therapeutics.
[55] M. Bickel,et al. Intracellular binding and metabolism of imipramine and imipramine-N-oxide. , 1971, Chemico-biological interactions.
[56] S. Colowick,et al. Binding of diffusible molecules by macromolecules: rapid measurement by rate of dialysis. , 1969, The Journal of biological chemistry.
[57] E. Perucca,et al. Plasma Protein Binding of Drugs in Pregnancy , 1982, Clinical pharmacokinetics.
[58] S. Dutta,et al. THE UPTAKE AND SUBCELLULAR DISTRIBUTION OF RADIO‐LABELLED METABOLITES OF DIGITOXIN IN THE GUINEA‐PIG ISOLATED PERFUSED HEART , 1976, British journal of pharmacology.
[59] J. Leysen,et al. Specific in vivo binding of neuroleptic drugs in rat brain. , 1977, Biochemical pharmacology.
[60] H. Rosenthal. A graphic method for the determination and presentation of binding parameters in a complex system. , 1967, Analytical biochemistry.
[61] R. Minchin,et al. Comparative uptake of quinine and quinidine in rat lung , 1981, The Journal of pharmacy and pharmacology.
[62] R. Branch,et al. The disposition of propranolol. VII. The effects of saturable hepatic tissue uptake on drug clearance by the perfused rat liver. , 1973, Drug metabolism and disposition: the biological fate of chemicals.
[63] V. Mlynárik,et al. Interaction of pirprofen enantiomers with human serum albumin. , 1991, Chirality.
[64] C. Cotman,et al. Analytical differential centrifugation: an analysis of the sedimentation properties of synaptosomes, mitochondria and lysosomes from rat brain homogenates. , 1970, Archives of biochemistry and biophysics.
[65] C. Longhini,et al. Subcellular distribution of deslanatoside C, ouabain and digitoxin in the heart and liver of conscious guinea pigs. , 1977, Biochemical pharmacology.
[66] C. Chignell. Optical studies of drug-protein complexes. IV. The interaction of warfarin and dicoumarol with human serum albumin. , 1970, Molecular pharmacology.
[67] P. Morselli,et al. Clinical Pharmacokinetics in Newborns and Infants , 1980 .
[68] S. Dutta,et al. Subcellular distribution of digoxin-H3 in isolated guinea-pig and rat hearts. , 1968, The Journal of pharmacology and experimental therapeutics.
[69] K. Piafsky. Disease-induced Changes in the Plasma Binding of Basic Drugs , 1980, Clinical pharmacokinetics.
[70] A. Wilson,et al. Uptake, metabolism and efflux of methadone in "single pass" isolated perfused rabbit lungs. , 1976, The Journal of pharmacology and experimental therapeutics.
[71] B. Brodie,et al. Physiological disposition and fate of chlorpromazine and a method for its estimation in biological material. , 1956, The Journal of pharmacology and experimental therapeutics.
[72] S. Månér,et al. Preparation and characterization of subcellular fractions from the head kidney of the Northern pike (Esox lucius), with particular emphasis on xenobiotic-metabolizing enzymes. , 1985, Biochemical pharmacology.
[73] P. A. Shore,et al. Distribution of clozapine in the rat: localization in lung. , 1978, The Journal of pharmacology and experimental therapeutics.
[74] T. Blanck,et al. β-Adrenergic receptor ligand binding by rabbit lung☆ , 1979 .
[75] T. Bjornsson,et al. Lidocaine plasma protein binding , 1980, Clinical pharmacology and therapeutics.
[76] T. Trnovec,et al. Kinetics of gentamicin accumulation in subcellular structures of the mouse kidney , 1982, The Journal of pharmacy and pharmacology.
[77] G. Dallner,et al. Isolation of rough and smooth microsomes from rat liver by means of a commerically available centrifuge. , 1969, Analytical biochemistry.
[78] I. Sjöholm,et al. Studies on the binding of benzodiazepines to human serum albumin by circular dichroism measurements. , 1976, Biochemical pharmacology.
[79] H. Nau,et al. Microscale ultrafiltration technique for determining free drug in 50-microL serum samples. , 1984, Clinical Chemistry.
[80] G R Wilkinson,et al. Clearance approaches in pharmacology. , 1987, Pharmacological reviews.
[81] S. Garattini,et al. Basic and Therapeutic Aspects of Perinatal Pharmacology , 1976 .
[82] N. Anderson,et al. Analytical techniques for cell fractions. 8. Analytical differential centrifugation in angle-head rotors. , 1968, Analytical Biochemistry.
[83] S. Dromgoole. The effect of haemodialysis on the binding capacity of albumin. , 1973, Clinica chimica acta; international journal of clinical chemistry.
[84] F. Andreasen,et al. Protein binding of drugs in plasma from patients with acute renal failure. , 2009, Acta pharmacologica et toxicologica.
[85] Klotz Im,et al. The Binding of Organic Ions by Proteins1 , 1946 .
[86] R. Wise. The Clinical Relevance of Protein Binding and Tissue Concentrations in Antimicrobial Therapy , 1986, Clinical pharmacokinetics.
[87] A. Rane,et al. Subcellular Distribution of Styrene Oxide in Rat Liver , 1984, Toxicologic pathology.
[88] L. Stern,et al. Sephadex G-25 quantitative estimation of free bilirubin potential in jaundiced newborn infants sera: a guide to the prevention of kernicterus. , 1972, The Journal of laboratory and clinical medicine.
[89] G. Wilkinson. Plasma and tissue binding considerations in drug disposition. , 1983, Drug metabolism reviews.
[90] T. Blaschke. Protein Binding and Kinetics of Drugs in Liver Diseases , 1977, Clinical pharmacokinetics.
[91] H. Mehendale,et al. Uptake and metabolism of chlorpromazine by rat and rabbit lungs. , 1980, Drug metabolism and disposition: the biological fate of chemicals.
[92] G. Scatchard,et al. THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS , 1949 .
[93] W. E. Lindup,et al. Interaction of 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid, an inhibitor of plasma protein binding in uraemia, with human albumin. , 1990, Biochemical pharmacology.
[94] D. Shand,et al. The Disposition of Propranolol , 1972 .
[95] M. Rowland. Protein Binding and Drug Clearance , 1984, Clinical pharmacokinetics.
[96] U. Wollert,et al. Interaction of benzodiazepine derivatives with bovine serum albumin-II. Circular dichroism studies. , 1976, Biochemical pharmacology.
[97] L. Storstein. Protein Binding of Cardiac Glycosides in Disease States , 1977, Clinical pharmacokinetics.
[98] F. L. Crane,et al. The purification and biochemical characterization of bovine liver nuclear membranes. , 1972, The Journal of biological chemistry.
[99] I. Sipes,et al. Liver slices in dynamic organ culture. II. An in vitro cellular technique for the study of integrated drug metabolism using human tissue. , 1991, Xenobiotica; the fate of foreign compounds in biological systems.
[100] A. Junod. ACCUMULATION OF 14C-IMIPRAMINE IN ISOLATED PERFUSED RAT LUNGS , 1972 .
[101] B. K. MARTIN,et al. Potential Effect of the Plasma Proteins on Drug Distribution , 1965, Nature.
[102] R. Gugler,et al. Drug Protein Binding and the Nephrotic Syndrome , 1976, Clinical pharmacokinetics.
[103] W J Jusko,et al. Plasma and tissue protein binding of drugs in pharmacokinetics. , 1976, Drug metabolism reviews.
[104] A. Amar‐Costesec,et al. Analytical study of microsomes and isolated subcellular membranes from rat liver VIII. Subfractionation of preparations enriched with plasma membranes, outer mitochondrial membranes, or Golgi complex membranes , 1981, The Journal of cell biology.
[105] J. T. Yang,et al. Comparison of circular dichrometers: normal and difference circular dichroism measurements. , 1972, Analytical biochemistry.
[106] J. Crooks,et al. Altered Plasma Protein Binding of Drugs in Thyroid Disease , 1981, Clinical pharmacokinetics.
[107] H. Mehendale,et al. Chlorphentermine uptake by isolated perfused rabbit lung. , 1980, Toxicology and applied pharmacology.
[108] T. Orton,et al. Accumulation of amines in the isolated perfused rabbit lung. , 1974, The Journal of pharmacology and experimental therapeutics.
[109] I. Sjöholm,et al. Binding of drugs to human serum albumin. XIV. The theoretical basis for the interaction between phenytoin and valproate. , 1980, Molecular pharmacology.
[110] G. Powis,et al. Human and dog, but not rat, isolated hepatocytes have decreased foreign compound-metabolizing activity compared to liver slices. , 1989, Drug metabolism and disposition: the biological fate of chemicals.
[111] W. E. Lindup. Plasma protein binding of drugs: some basic and clinical aspects , 1987 .
[112] M. Reidenberg. The Binding of Drugs to Plasma Proteins from Patients with Poor Renal Function , 1976, Clinical pharmacokinetics.
[113] R. Anderson,et al. Hepatic uptake of propranolol. , 1978, The Journal of pharmacology and experimental therapeutics.
[114] B. Fichtl,et al. Tissue Binding versus Plasma Binding of Drugs: General Principles and Pharmacokinetic Consequences , 1991 .
[115] P. Rehberg. A Centrifugation Method of Ultraflltration Using Cellophane Tubes , 1943 .
[116] B. Veering,et al. The effect of age on serum concentrations of albumin and alpha 1-acid glycoprotein. , 1990, British journal of clinical pharmacology.
[117] M. Barry,et al. Severity of cirrhosis and the relationship of α1‐acid glycoprotein concentration to plasma protein binding of lidocaine , 1990 .
[118] J. Mackichan. Pharmacokinetic Consequences of Drug Displacement from Blood and Tissue Proteins , 1984, Clinical pharmacokinetics.
[119] W. Rummel,et al. Stereospecificity of anesthetic activity, distribution, inactivation and protein binding of the optical antipodes of two N-methylated barbiturates. , 1970, The Journal of pharmacology and experimental therapeutics.
[120] I. Sjöholm,et al. Independent binding of ligands to human serum albumin. , 1977, The Journal of biological chemistry.
[121] P. Laduron. Tissue fractionation in neurobiochemistry: an analytical tool or a source of artifacts. , 1977, International review of neurobiology.
[122] M. Eichelbaum,et al. Stereoselective protein binding of verapamil enantiomers. , 1988, Biochemical pharmacology.
[123] M. J. Smith,et al. The relation between circulating and tissue concentrations of salicylate in the mouse in vivo , 1970, The Journal of pharmacy and pharmacology.
[124] D. Wallach,et al. Isolation of plasma membrane vesicles from animal cells. , 1977, Methods in cell biology.
[125] T. Trnovec,et al. Interaction of propafenone enantiomers with human alpha 1-acid glycoprotein. , 1991, Chirality.
[126] M. Eadie,et al. Plasma protein binding of diphenylhydantoin Effects of sex hormones, renal and hepatic disease , 1974, Clinical pharmacology and therapeutics.
[127] Y. Sawada,et al. Effect of sulfadimethoxine on thiopental distribution and elimination in rats. , 1981, Journal of pharmaceutical sciences.
[128] I. Kopin,et al. Subcellular distribution of Δ9-tetrahydrocannabinol in rat brain , 1974 .
[129] S. Paul,et al. Subcellular distribution of high affinity [3H]imipramine binding and [3H]serotonin uptake in rat brain. , 1983, European journal of pharmacology.
[130] C. Cerletti,et al. 3H-reserpine persistently bound "in vivo" to rat brain subcellular components: limited removal by peanut oil extraction. , 1974, Life sciences.
[131] L. Manara,et al. DRUG DISTRIBUTION IN THE BRAIN , 1978 .
[132] D. Perrier,et al. The "ultra-free" ultrafiltration technique compared with equilibrium dialysis for determination of unbound thiopental concentrations in serum. , 1981, Clinical chemistry.
[133] A. Rane,et al. Nuclear epoxide hydrolase in the human fetal and adult liver. , 1984, Pharmacology.
[134] M. Reidenberg. Effect of disease states on plasma protein binding of drugs. , 1974, The Medical clinics of North America.
[135] H. Paulus. A rapid and sensitive method for measuring the binding of radioactive ligands to proteins. , 1969, Analytical biochemistry.
[136] J. Pritchard,et al. Studies on the uptake and binding of propranolol by rat tissues. , 1977, The Journal of pharmacology and experimental therapeutics.
[137] C T Dollery,et al. CONCENTRATION OF (±)‐PROPRANOLOL IN ISOLATED, PERFUSED LUNGS OF RAT , 1976, British journal of pharmacology.
[138] W. Jusko,et al. Theophylline tissue partitioning and volume of distribution in normal and dietary-induced obese rats. , 1987, Biopharmaceutics & drug disposition.
[139] W. Jusko,et al. Distribution volume related to body weight and protein binding. , 1982, Journal of pharmaceutical sciences.
[140] A. Schibeci,et al. The binding of arsenazo III to cell components. , 1980, Biochimica et biophysica acta.
[141] J. McElnay,et al. Drug interactions involving the displacement of drugs from plasma protein and tissue binding sites. , 1982, Pharmacology & therapeutics.
[142] R. Verbeeck,et al. Plasma Protein Binding of Drugs in the Elderly , 1987, Clinical pharmacokinetics.
[143] R. Branch,et al. A study of factors influencing drug disposition in chronic liver disease, using the model drug (+)-propranolol. , 1976, British Journal of Clinical Pharmacology.
[144] Y. Sugiyama,et al. Effect of quinidine on the tissue binding of digoxin in guinea‐pigs , 1986, The Journal of pharmacy and pharmacology.
[145] E. Rolleri,et al. Use of serum albumin microspheres as a reversible adsorbent for studying protein-small molecule interactions. , 1973, Biochimica et biophysica acta.
[146] John T. Wilson,et al. Clinical Pharmacokinetics in Infants and Children , 1976, Clinical pharmacokinetics.
[147] J. Zaroslinski,et al. Protein binding methodology: comparison of equilibrium dialysis and frontal analysis chromatography in the study of salicylate binding. , 1972, Analytical biochemistry.
[148] C. Eap,et al. Binding of d‐methadone, 1‐methadone, and dl‐methadone to proteins in plasma of healthy volunteers: Role of the variants of α1‐acid glycoprotein , 1990, Clinical pharmacology and therapeutics.
[149] A. Holmgren,et al. Tissue distrubution and subcellular localization of bovine thioredoxin determined by radioimmunoassay. , 1978, Biochemistry.
[150] Lindup We,et al. Excretion of the uraemic metabolite 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid in human urine. , 1990 .
[151] P. Morselli,et al. Studies on plasma protein binding of carbamazepine. , 1974, Pharmacological research communications.
[152] S. Jacobsen,et al. Binding of quinidine in serum and heart from normal and anuric rats, and the significance for distribution. , 1979, Biochemical pharmacology.
[153] J. Konopa,et al. In vitro binding of metabolically activated [14C]-ledakrin, or 1-nitro-9-14C-(3'-dimethylamino-N-propylamino) acridine, a new antitumor and DNA cross-linking agent, to macromolecules of subcellular fractions isolated from rat liver and HeLa cells. , 1979, Biochemical pharmacology.
[154] R. Kuntzman,et al. Importance of tissue and plasma binding in determining the retention of norchlorcyclizine and norcyclizine in man, dog and rat. , 1967, The Journal of pharmacology and experimental therapeutics.
[155] C. Danpure,et al. The uptake and subcellular distribution of gold in rat liver cells after in vivo administration of sodium aurothiomalate. , 1977, Biochemical pharmacology.
[156] G. Placidi,et al. Subcellular distribution of pinazepam and its metabolite N-desmethyldiazepam in rat liver. , 1984, General pharmacology.
[157] I. Sjöholm,et al. Correlation between arginyl residue modification and benzodiazepine binding to human serum albumin. , 1977, Journal of Biological Chemistry.
[158] F. Andreasen,et al. The binding of thiopental to serum proteins determined by ultrafiltration and equilibrium dialysis. , 2009, Acta pharmacologica et toxicologica.
[159] D. Drayer,et al. Alteration of Drug-Protein Binding in Renal Disease , 1984, Clinical pharmacokinetics.
[160] H. Nau,et al. Decreased serum protein binding of diazepam and its major metabolite in the neonate during the first postnatal week relate to increased free fatty acid levels. , 1984, British journal of clinical pharmacology.
[161] J. Tillement,et al. Diseases and Drug Protein Binding , 1978, Clinical pharmacokinetics.
[162] G. Powis,et al. A high-performance liquid chromatography assay for measuring integrated biphenyl metabolism by intact cells: its use with rat liver and human liver and kidney. , 1987, Analytical biochemistry.
[163] G. Levy,et al. Serum protein binding of drugs and bilirubin in newborn infants and their mothers , 1980, Clinical pharmacology and therapeutics.
[164] K. Netter. Progress in drug metabolism , 1985 .
[165] M. Contin,et al. Stereoselective binding of propranolol enantiomers to human alpha 1-acid glycoprotein and human plasma. , 1984, British journal of clinical pharmacology.
[166] H. Kurz,et al. Binding of Drugs to Human Skin: Influencing Factors and the Role of Tissue Lipids , 1988, The Journal of pharmacy and pharmacology.
[167] Malcolm Rowland,et al. Clinical pharmacokinetics : concepts and applications , 1989 .
[168] A. Danon,et al. Binding of imipramine to plasma proteins: Effect of hyperlipoproteinemia , 1979, Clinical pharmacology and therapeutics.
[169] P. McNamara,et al. Stereoselective binding of propranolol in the elderly. , 1989, British journal of clinical pharmacology.
[170] F. Sjöqvist,et al. Increased plasma protein binding of propranolol and chlorpromazine mediated by disease-induced elevations of plasma alpha1 acid glycoprotein. , 1978, The New England journal of medicine.
[171] R. Kay,et al. Rapid isolation of nuclear envelopes from rat liver. , 1977, Methods in cell biology.
[172] M D Hill,et al. The Significance of Plasma Protein Binding on the Fetal/Maternal Distribution of Drugs at Steady-State , 1988, Clinical pharmacokinetics.